Stock · DRW3.DE · Healthcare
Germany · Small Cap · Revenue 12 mo. €3.6B
Price as of 11/06/2026
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide.
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas measurement technology, and comprehensive risk management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. In addition, it offers patient monitoring systems; anaesthesia machines; medical ventilators and lung monitoring; neonatal incubators and thermoregulation; phototherapy lights and bilirubinometers; surgical and examination lights; medical pendants and infrastructure design; medical gas pipeline system in hospitals; and hospital consumables and accessories, as well as hospital planning and design services. Further, the company offers alcohol and drug testing; diving equipment; fixed gas detectors; hazmat suits; portable gas detection; head and eye protection; rescue and escape; respiratory protection; safety-training systems; thermal imaging cameras; and workshop solution and breathing gas supply, as well as provides various training and services. The company was founded in 1889 and is headquartered in Lübeck, Germany. Drägerwerk AG & Co. KGaA operates as a subsidiary of Dr. Heinrich Dräger GmbH.
Original text from the data provider
Summary
46.2 of 100
Mean of the six area values. Each area value is the mean of the stock's ranks among the companies in its sector. 50 is the middle of the sector, not a share of companies beaten.
Analysis
What the price requires
If free cash flow stays at €166.5M (2025), it supports €1.9B. The remaining €82.2M of the market value assume it grows 0.6% a year for 10 years and not at all afterwards.
Required FCF growth per year
0.6%
no growth afterwards
Price to operating cash flow 6.9×, above its usual range.
Middle half of 16 quarters: 4.3× to 5.8×, median 5.2×.
Measures only against its own past, not against what the company is worth. Price as of 11/06/2026.
with respect to the priced-in expectation
with respect to the priced-in expectation
Since the last quarter
Q1 → Q2 2026
6 more unchanged: Revenue, 12 mo., Gross margin, EBIT margin, FCF margin, Shares outstanding, Return on equity
Derivation
Each area value is the average of its metrics' ranks within the sector (0 to 100, 50 is the middle). For metrics where lower is better, the rank is mirrored. The overall value is the average of the area values.
Price as of 11/06/2026.
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Return on equity | 8.58% | 11.52% | Rank 37 |
| Return on capital (Greenblatt) | 15.58% | 32.55% | Rank 18 |
| EBIT margin | 6.84% | 18.31% | Rank 19 |
| FCF margin | 4.78% | 14.12% | Rank 21 |
| Gross margin | 43.52% | 60.99% | Rank 27 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Revenue growth, 1 year | 3.29% | 8.04% | Rank 24 |
| Earnings growth, 3 years per yeardoes not count towards the rank | – | 5.44% | |
| Earnings growth, 5 years per year | −11.30% | 7.00% | Rank 12 |
| Sustainable growth (ROE × retained earnings) | 2.06% | 3.66% | Rank 24 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Earnings yield | 7.21% | 2.90% | Rank 93 |
| FCF yield | 8.62% | 3.63% | Rank 93 |
| EV/saleslower is better | 0.59 | 4.03 | Rank 90 |
| EV/EBITlower is better | 8.62 | 21.73 | Rank 98 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Share price, 1 year | 43.51% | 8.66% | Rank 86 |
| Share price, 6 months | 15.41% | 24.27% | Rank 40 |
| Share price, 3 months | −1.22% | 15.42% | Rank 12 |
| Distance from 52-week high | −17.17% | −7.35% | Rank 25 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Accruals (Sloan)lower is better | −0.02% | 0.30% | Rank 53 |
| Change in share countlower is better | −0.12% | 0.00% | Rank 53 |
| Dividend streak in years | 4 | 10 | Rank 46 |
| Price reaction to results, market-adjusted | −0.96% | 0.05% | Rank 37 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Equity ratio | 49.63% | 48.40% | Rank 50 |
| Net debt/EBITDAlower is better | 0.31 | 1.11 | Rank 63 |
| Debt to equitylower is better | 0.25 | 0.48 | Rank 67 |
| Volatility, 1 yearlower is better | 39.20% | 31.42% | Rank 29 |
Ten years in figures
| Year | Revenue, €B | EBIT margin | FCF, €M | Shares | Net debt, €M |
|---|---|---|---|---|---|
| 2016 | 2.5 | 6.1% | 115.6 | 17.8M | 40.1 |
| 2017 | 2.6 | 6.0% | 72.6 | 17.8M | −24.2 |
| 2018 | 2.6 | 2.5% | −57.6 | 17.8M | 47.6 |
| 2019 | 2.8 | 3.0% | 100.0 | 17.8M | 96.6 |
| 2020 | 3.4 | 12.1% | 345.0 | 18.5M | −121.5 |
| 2021 | 3.3 | 8.4% | 274.5 | 18.8M | −91.4 |
| 2022 | 3.0 | −2.6% | −231.1 | 18.8M | 59.5 |
| 2023 | 3.4 | 5.5% | 121.5 | 18.8M | 199.4 |
| 2024 | 3.4 | 5.0% | 103.5 | 18.8M | 172.1 |
| 2025 | 3.5 | 6.8% | 166.5 | 18.7M | 123.0 |
2 of 7 StockScorer Score rules met · How the score is built
Drägerwerk AG & Co. KGaA (pref) mainly meets criteria in the Valuation category. Result from 18 strategies checked.
Drägerwerk AG & Co. KGaA (pref) is rated here with the StockScorer Score strategy, the flagship rule set. It compares return and cash-flow metrics with the median of the company's own sector and checks growth and price trend.
2 of 7 rules met
3 of 11 points
Detail data
Excerpt from 18 strategies checked. The full evaluation is visible after a free sign-up.
With a free account, you can see the match across all strategies checked in one complete overview.
Selected fundamental metrics for Drägerwerk AG & Co. KGaA (pref).
| Metric | Stock | Sector |
|---|---|---|
| P/E ratio | 13.9 | 30.0 |
| P/B ratio | 1.2 | 4.8 |
| Return on equity (ROE) | 8.6% | 11.5% |
| Equity ratio | 49.6% | 48.4% |
| Debt-to-equity (D/E) | 0.25 | 0.48 |
| Dividend yield | 2.2% | 1.3% |
How comparable stocks in the same sector score in the StockScorer model.
| Symbol | Company | Rating |
|---|---|---|
| DRW3.DE | Drägerwerk AG & Co. KGaA (pref)this page | |
| EUZ.DE | Eckert & Ziegler Strahlen- und Medizintechnik AG | Low3.6 |
| PODD | Insulet Corporation | Medium5.5 |
| DEMANT.CO | Demant A/S | locked |
| 7733.T | Olympus Corp. | locked |
| SN.L | Smith & Nephew PLC | locked |
Signed up in 30 seconds, free.
Learn more about the metrics in the metrics glossary or all rated stocks in the stock overview.
How StockScorer rates every stock is explained on the methodology page.